Crane
CR
203.55
-5.37
-2.57%
Crane
US · CR
#1321 by market cap
Listed 2023
203.55
-5.37
-2.57%
Live - 5344 symbols - heartbeat 431s ago
· 2026-10-08 07:41
Pre-market
203.55
0.00%
After-hours
203.55
0.00%
Overnight
202.13
-0.70%
- Market cap
- 11.77B
- P/E (TTM)i
- 35.52
- P/Bi
- 5.40
- EPSi
- 6.26
- Div yieldi
- 0.48%
- 52W posi
- 62%
Reader sentiment
Are you bullish or bearish on CR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.12, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +8.16% YoY
Margins
- Gross margin
- 42.20%
- Operating margin
- 18.40%
- Net margin
- 15.90%
Key ratios & quality
- Enterprise valuei
- 12.42B
- Altman Z-Scorei
- 6.12
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.35B | 3.07B | 2.94B | 2.06B | 1.78B | 1.86B | 2.13B | 2.31B |
| Gross profit | 1.19B | 1.13B | 1.01B | 688.80M | 661.20M | 751.00M | 867.80M | 972.80M |
| Selling & admin expenses | 711.90M | 678.60M | 698.10M | 467.10M | 493.50M | 500.60M | 512.00M | 548.60M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 477.40M | 205.80M | 308.10M | 221.70M | 167.70M | 250.40M | 355.80M | 424.20M |
| Pretax profit | 411.40M | 143.90M | 224.50M | 233.70M | 236.50M | 233.10M | 338.50M | 432.80M |
| Tax | 75.90M | 31.30M | 43.40M | 36.30M | 70.10M | 57.20M | 70.30M | 101.10M |
| Net profit | 335.50M | 133.60M | 181.10M | 435.40M | 401.10M | 255.90M | 294.70M | 366.60M |
| Basic EPS | 6 | 2 | 3 | 7 | 7 | 5 | 5 | 6 |
| Diluted EPS | 5.50 | 2.20 | 3.08 | 7.36 | 7.01 | 4.45 | 5.05 | 6.26 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 557.60M | 577.20M | 589.20M | 581.00M | 696.40M | 724.70M |
| Gross profit | 237.60M | 242.30M | 251.30M | 241.60M | 281.30M | 307.50M |
| Selling & admin expenses | 136.50M | 139.40M | 132.90M | 139.80M | 181.20M | 163.20M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 101.10M | 102.90M | 118.40M | 101.80M | 100.10M | 144.30M |
| Pretax profit | 98.80M | 104.60M | 120.40M | 109.00M | 85.10M | 128.00M |
| Tax | 20.50M | 24.30M | 29.00M | 27.30M | 18.00M | 32.10M |
| Net profit | 107.10M | 86.40M | 91.40M | 81.70M | 67.10M | 95.90M |
| Basic EPS | 2 | 2 | 2 | 1 | 1 | 2 |
| Diluted EPS | 1.83 | 1.47 | 1.56 | 1.39 | 1.14 | 1.63 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.36B | 1.50B | 1.57B | 1.54B | 1.75B | 1.09B | 1.40B | 2.57B |
| Cash & ST investments | 343.40M | 393.90M | 551.00M | 478.60M | 427.00M | 329.60M | 306.70M | 506.50M |
| Inventory | 411.50M | 457.30M | 429.70M | 449.10M | 294.20M | 343.90M | 380.40M | 376.50M |
| Total assets | 4.04B | 4.42B | 4.62B | 4.49B | 4.39B | 2.35B | 2.64B | 3.85B |
| Total current liabilities | 740.20M | 916.70M | 1.06B | 789.30M | 1.49B | 467.10M | 543.40M | 465.20M |
| Short-term debt | 6.90M | 173.40M | 398.70M | 22.70M | 411.20M | 10.40M | 13.00M | 13.60M |
| Long-term debt | 942.30M | 842.00M | 842.90M | 842.40M | -- | 248.50M | 247.00M | 1.15B |
| Total liabilities | 2,515,600,000.00 | 2,947,400,000.00 | 3,083,900,000.00 | 2,651,500,000.00 | 2,487,600,000.00 | 991,100,000.00 | 1,000,900,000.00 | 1,790,000,000.00 |
| Total equity | 1.53B | 1.48B | 1.53B | 1.84B | 1.90B | 1.36B | 1.64B | 2.06B |
| Retained earnings | 2.07B | 2.11B | 2.19B | 2.53B | 2.82B | 960.70M | 1.22B | 1.53B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.37B | 1.25B | 1.28B | 2.57B | 1.48B | 1.48B |
| Cash & ST investments | 435.10M | 332.20M | 388.20M | 506.50M | 355.40M | 350.40M |
| Inventory | 391.60M | 402.20M | 394.70M | 376.50M | 507.10M | 507.20M |
| Total assets | 2.62B | 2.52B | 2.55B | 3.85B | 4.05B | 4.03B |
| Total current liabilities | 659.50M | 425.50M | 392.00M | 465.20M | 520.20M | 527.50M |
| Short-term debt | 259.90M | 60.30M | 13.50M | 13.60M | 22.30M | 28.60M |
| Long-term debt | -- | -- | -- | 1.15B | 1.19B | 1.09B |
| Total liabilities | 862,900,000.00 | 628,000,000.00 | 580,500,000.00 | 1,790,000,000.00 | 1,952,500,000.00 | 1,850,900,000.00 |
| Total equity | 1.76B | 1.89B | 1.97B | 2.06B | 2.10B | 2.18B |
| Retained earnings | 1.31B | 1.38B | 1.46B | 1.53B | 1.58B | 1.67B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 413.80M | 393.80M | 309.50M | 498.50M | -498.80M | 162.10M | 257.80M | 394.80M |
| Depreciation & amortization | 120.00M | 107.90M | 127.50M | 38.40M | 33.70M | 35.40M | 51.00M | 50.20M |
| Free cash flow | 305.00M | 329.40M | 275.40M | 463.20M | -532.10M | 123.10M | 221.20M | 341.30M |
| Dividends paid | -83.50M | -93.20M | -100.40M | -100.60M | -105.90M | -57.30M | -46.90M | -52.90M |
| Stock buybacks / issuance | -50.10M | -79.90M | -70.00M | -96.30M | -203.70M | -- | -- | -- |
| Ending cash balance | 343.40M | 393.90M | 551.00M | 478.60M | 657.60M | 329.60M | 308.20M | 1.73B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -46.20M | 105.00M | 130.20M | 205.80M | -29.50M | 122.30M |
| Depreciation & amortization | 12.50M | 13.10M | 12.20M | 12.40M | 28.10M | 27.40M |
| Free cash flow | -60.40M | 88.90M | 116.80M | 196.00M | -40.20M | 107.70M |
| Dividends paid | -13.20M | -13.20M | -13.30M | -13.20M | -14.70M | -14.70M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 435.10M | 332.20M | 388.20M | 1.73B | 355.40M | 350.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 23.39 | 8.89 | 12.06 | 25.91 | 21.49 | 15.70 | 19.67 | 19.82 |
| ROA %i | 8.79 | 3.15 | 4.02 | 9.60 | 9.04 | 7.61 | 11.85 | 11.29 |
| ROIC %i | 16.45 | 6.64 | 8.24 | 16.79 | 14.48 | 10.96 | 17.18 | 14.01 |
| 5-year avg ROE %i | 17.18 | 15.55 | 13.80 | 16.82 | 18.35 | 16.81 | 18.96 | 20.52 |
| EBIT margin %i | 13.82 | 6.62 | 9.53 | 16.48 | 18.23 | 13.89 | 17.16 | 19.27 |
| FCF / sales %i | 9.12 | 9.90 | 9.38 | 14.05 | -- | 8.89 | 10.38 | 14.81 |
| Current ratioi | 1.84 | 1.64 | 1.49 | 1.96 | 1.18 | 2.34 | 2.58 | 5.53 |
| Quick ratioi | 1.18 | 1.05 | 0.94 | 1.24 | 0.47 | 1.34 | 1.19 | 1.86 |
| Debt / assetsi | 23.48 | 25.02 | 28.78 | 21.05 | 10.50 | 13.39 | 12.09 | 31.56 |
| LT debt / equityi | 61.82 | 63.34 | 60.78 | 50.31 | 2.61 | 22.42 | 18.69 | 58.35 |
| Interest coveragei | 9.08 | 4.65 | 5.06 | 11.18 | 11.79 | 12.76 | 13.44 | 39.30 |
| Revenue CAGR (3Y) %i | 6.88 | 3.81 | 1.77 | -14.89 | -16.71 | -14.09 | 1.09 | 9.07 |
| Net income CAGR (3Y) %i | 13.60 | 2.77 | 1.75 | 9.07 | 44.37 | 12.24 | -12.20 | -2.95 |
| FCF CAGR (3Y) %i | 17.15 | 7.31 | 0.85 | 14.94 | -- | -23.54 | -21.84 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 21.32 | 20.94 | 20.67 | 19.82 | 16.95 | 16.54 |
| ROA %i | 13.37 | 14.01 | 14.07 | 11.29 | 9.79 | 10.27 |
| ROIC %i | 19.78 | 20.29 | 20.26 | 14.01 | 10.34 | 11.28 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 17.80 | 18.17 | 18.73 | 19.27 | 18.12 | 18.46 |
| FCF / sales %i | 11.42 | 12.75 | 14.70 | 14.81 | 14.79 | 14.68 |
| Current ratioi | 2.08 | 2.93 | 3.27 | 5.53 | 2.85 | 2.80 |
| Quick ratioi | 1.24 | 1.68 | 1.98 | 1.86 | 1.63 | 1.59 |
| Debt / assetsi | 9.91 | 2.40 | 0.53 | 31.56 | 29.98 | 27.68 |
| LT debt / equityi | -- | -- | -- | 58.35 | 56.87 | 49.92 |
| Interest coveragei | 15.82 | 18.91 | 28.13 | 39.30 | 18.76 | 13.33 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Process Flow Technologies is the largest reported line at 53.21% of revenue, across 2 reported segments.
- Aerospace & Advanced Technologies follows at 46.79%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Process Flow Technologies53.21%
Aerospace & Advanced Technologies46.79%
Quote time 2026-10-08 07:41:47 · For reference only, not investment advice and not tailored to your situation.